Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Logout MarketXLS
Regulus Therapeutics Inc. logo

Regulus Therapeutics Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

1.71
 
USD
  
0.00
  
(0.00%)
Optionable: Yes  Market Cap: 29 M  90-day average vol: 859,644

Previous close: 1.71  Open: 1.7  Bid: 1.77  Ask: 1.77
52 week range    
1.33   
   4.00
Peers   
SNY / 
ALNY / 
GSK / 
BIIB / 
BMY / 
SGMO / 
Last updated: Thursday 1st December 2022
58
MarketXLS Rank marketxls
60
Value marketxls
69
Technical marketxls
47
Quality marketxls

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock
Are you?
twitterstocktwits
Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

17 B-19.3148.65

AZN

BIIB

34 B21.6221.3

BMY

0.0332145 B-27.366.19

GSK

SGMO

1 B-4.75.72

SNY

News
Financials

RGLS Income Statement

Annual

Dec-12Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues13 M20 M8 M21 M1 M72000720007 M10 M0
Cost of sales-1 M-3 M-3 M-3 M-3 M-3 M-2 M-931000-467000-459000
Gross operating profit13 M20 M8 M21 M1 M72000720007 M10 M0
Selling Gen & administrative expense5 M7 M12 M19 M18 M17 M13 M11 M9 M10 M
Research & development expense20 M30 M41 M56 M64 M53 M34 M12 M15 M18 M
Operating income-13 M-18 M-45 M-55 M-82 M-70 M-47 M-17 M-14 M-28 M
floaterest income0000000000
floaterest expense0000000000
Other income net-5 M-1 M-12 M-2 M-338000-2 M-2 M-2 M-2 M9000
Pre-tax Income (EBT)-17 M-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M
Income taxes-10000-230001000-18000-4000-19700062000100001000
Net income from total operations-17 M-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M
Minority floaterest0000000000
Total net income-17 M-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-17 M-19 M-57 M-56 M-82 M-72 M-49 M-19 M-16 M-28 M
Depreciation1 M3 M3 M3 M3 M3 M2 M931000467000459000
Amortization0000000000
Operating income before depreciation (EBITDA)-16 M-17 M-55 M-54 M-78 M-67 M-44 M-16 M-13 M-26 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-25.44-5.88-15.48-12.96-18.6-11.47-5.59-1.08-4.5-3.2
Diluted EPS total-25.44-5.88-15.48-12.96-18.6-11.47-5.59-1.08-4.5-3.2
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today